RxSight, Inc. (RXST) Form 10-Q Quarterly Reports
RxSight, Inc. (RXST) is a publicly traded company on the Nasdaq, categorized under SIC 3851 (Ophthalmic Goods). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RXST
CIK: 1111485
Exchange: Nasdaq
SIC 3851: Ophthalmic Goods
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMary Garrett
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-16 | 2026-09-15 | 4 Filing | 0001295814-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-05 | 4 | 0001193125-26-386841 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-05 | 4 | 0001193125-26-386840 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-05 | 4 | 0001193125-26-386838 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-05 | 4 | 0001193125-26-386837 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-09-08 | — | SC TO-I/A | 0001193125-26-385375 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001295469-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0002107187-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001874147-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001295814-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380714 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380713 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380711 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380710 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-08-25 | — | SC TO-I/A | 0001193125-26-363948 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-19 | — | SCHEDULE 13G Filing | 0000919574-26-005630 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008359 | View SEC Doc Filr Page |
| SC TO-I | 2026-08-10 | — | SC TO-I | 0001193125-26-341304 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335153 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335150 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-04 | — | SCHEDULE 13G/A Filing | 0001104659-26-090567 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-24 | 4 | 0001193125-26-316544 | View SEC Doc Filr Page |
| 3 | 2026-07-24 | 2026-07-20 | 3 | 0001193125-26-316541 | View SEC Doc Filr Page |
| S-8 | 2026-07-23 | — | S-8 | 0001193125-26-314252 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-17 | — | SCHEDULE 13G Filing | 0002052113-26-000736 | View SEC Doc Filr Page |